Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

364
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
364
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Biostatistics: Overview01:20

Biostatistics: Overview

239
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
239
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

123
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
123

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Improving medicines use in people with polypharmacy in primary care: a synopsis from the IMPPP cluster-RCT with pilot-feasibility study.

Health and social care delivery research·2026
Same author

Preserving a Functional Foot: Limb-Salvage Surgery with Brachy Mono-Therapy for Soft Tissue Sarcoma.

Indian journal of surgical oncology·2026
Same author

What is meant when we say we are clustering multimorbidity?

The lancet. Healthy longevity·2026
Same author

Cardiometabolic multiple long-term conditions: a tractable focus for a field challenged by heterogeneity?

Lancet (London, England)·2026
Same author

Correction to: From Dry Cavities to Healing Pathways: Innovations in Managing Empty Nose Syndrome.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2026
Same author

Accelerated deficit accumulation in frailty and associations with adverse outcomes: a longitudinal population data analysis.

The lancet. Healthy longevity·2026

相关实验视频

Updated: Jun 30, 2025

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

低条件计数的多病态分析:对于小但重要的子组,一个强大的贝叶斯方法.

Guillermo Romero Moreno1, Valerio Restocchi1, Jacques D Fleuriot1

  • 1School of Informatics, University of Edinburgh, Edinburgh, UK.

EBioMedicine
|March 22, 2024
PubMed
概括

一个新的贝叶斯框架改进了对老年人长期疾病关联的分析,即使数据有限. 这种方法提高了多病症研究和疾病机制研究的可靠性.

关键词:
关联措施 关联措施贝叶斯的推理 贝叶斯的推理较低的数量是低的数量.多种疾病多重症.网络分析 网络分析相对风险是一种相对风险.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

相关实验视频

Last Updated: Jun 30, 2025

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

科学领域:

  • 老年学是指老年学的学科.
  • 生物统计学 生物统计学
  • 流行病学 流行病学

背景情况:

  • 检查长期疾病关联对于多病症干预至关重要,但由于数据稀少,具有挑战性.
  • 最年长的老年人群面临着独特的挑战,因为对并发病的数据有限.

研究的目的:

  • 开发和应用一个贝叶斯推理框架,对稀疏的数据具有稳定性,用于量化发病率关联.
  • 在分析并发症网络时,将拟议的机会之外的协会 (ABC) 测量与标准的相对风险 (RR) 进行比较.

主要方法:

  • 在苏格兰,2007年3月,对12009名90岁以上的初级保健患者进行了回顾性横截面研究.
  • 对40种长期疾病的分析,按性别分层,比较RR和新ABC测量.
  • 建立协会网络,以探索条件相互作用和RR和ABC估计之间的差异.

主要成果:

  • 贝叶斯框架在稀疏的数据中表现出适当的谨慎,特别是对于不常见的条件.
  • 这种谨慎的方法影响了综合的多病症指标和网络表示,包括性别特异性差异.
  • 在使用RR与ABC估计时观察到关联分析的差异.

结论:

  • 纳入不确定性在多病症研究中至关重要,以防止在小子组中产生误导性发现.
  • 拟议的贝叶斯框架提高了关联估计和研究疾病机制和多病症的可靠性.